Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Symmetry Group Ltd.
Symbotic Reports Third Quarter Fiscal Year 2025 Results
Business
Aug 6 2025
21 min read

Symbotic Reports Third Quarter Fiscal Year 2025 Results

news images

WILMINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its third quarter of fiscal year 2025, which ended on June 28, 2025. Symbotic reported revenue of $592 million, a net loss of $32 million and adjusted EBITDA1 of $45 million for the third quarter of fiscal year 2025.

In comparison, Symbotic posted revenue of $470 million, a net loss of $27 million and adjusted EBITDA1 of $3 million in the third quarter of fiscal year 2024.

Cash and cash equivalents decreased by $177 million from the prior quarter, totaling $778 million at the end of the third quarter of fiscal year 2025.

“We continue to deliver strong results and drive operational progress,” said Rick Cohen, Symbotic Chairman and Chief Executive Officer. “We are building on this momentum with game-changing innovations that are unlocking new opportunities across the supply chain as we have unveiled with our next generation storage structure.”

“Revenue grew 26% and gross margins improved once again year-over-year,” said Carol Hibbard, Symbotic Chief Financial Officer. “Looking ahead, with the launch of a proprietary new storage structure, we expect a temporary short-term impact on revenue based on schedules shifting to accommodate. Importantly, the new structure does not affect our backlog and supports our long-term value creation.”

OUTLOOK

For the fourth quarter of fiscal 2025, Symbotic expects revenue of $590 million to $610 million, and adjusted EBITDA2 of $45 million to $49 million.

WEBCAST INFORMATION

Symbotic will host a webcast today at 5:00 pm ET to discuss its third quarter of fiscal year 2025 results. The webcast link is: https://edge.media-server.com/mmc/go/Symbotic-Q3-2025.

_______________
1 Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is a non-GAAP financial measure as defined below under “Use of Non-GAAP Financial Information.” See the tables below for reconciliations to net loss, the most comparable GAAP measure.

2 Symbotic is not providing guidance for net loss, which is the most comparable GAAP financial measure to adjusted EBITDA, because information reconciling forward-looking adjusted EBITDA to net loss is unavailable to it without unreasonable effort. Symbotic is not able to provide reconciliations of adjusted EBITDA to GAAP financial measures because certain items required for such reconciliations are outside of Symbotic’s control and/or cannot be reasonably predicted, such as restructuring charges and the provision for stock-based compensation.

ABOUT SYMBOTIC

Symbotic is an automation technology leader reimagining the supply chain with its end-to-end, A.I.-powered robotic and software platform. Symbotic reinvents the warehouse as a strategic asset for the world’s largest retail, wholesale, and food & beverage companies. Applying next-generation

technology, high-density storage and machine learning to solve today's complex distribution challenges, Symbotic enables companies to move goods with unmatched speed, agility, accuracy and efficiency. As the backbone of commerce, Symbotic transforms the flow of goods and the economics of the supply chain for its customers. For more information, visit www.symbotic.com.

USE OF NON-GAAP FINANCIAL INFORMATION

Symbotic reports its financial results in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). This press release contains financial measures that are not recognized under U.S. GAAP (“non-GAAP financial measures”), including adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow. These non-GAAP financial measures have limitations as an analytical tool as they do not have a standardized meaning prescribed by U.S. GAAP. The non-GAAP financial measures Symbotic uses may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as that of other companies and, therefore, are unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP financial measures are provided as a supplement to corresponding U.S. GAAP measures to provide additional information regarding the results of operations from management’s perspective. Accordingly, non-GAAP financial measures should not be considered a substitute for, in isolation from, or superior to, the financial information prepared and presented in accordance with U.S. GAAP. All non-GAAP financial measures presented in this press release are reconciled to their closest reported U.S. GAAP financial measures. Symbotic recommends that investors review the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures provided in the financial statement tables included below in this press release, and not rely on any single financial measure to evaluate its business.

Symbotic defines adjusted EBITDA, a non-GAAP financial measure, as GAAP net loss excluding the following items: interest income; income taxes; depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; equity method investment; internal control remediation; business transformation costs; fair value adjustments on strategic investments; restructuring charges; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines adjusted gross profit, a non-GAAP financial measure, as GAAP gross profit excluding the following items: depreciation, stock-based compensation, and restructuring charges. Symbotic defines adjusted gross profit margin, a non-GAAP financial measure, as adjusted gross profit divided by total revenue. Symbotic defines adjusted research and development expenses, a non-GAAP financial measure, as GAAP research and development expenses excluding the following items: depreciation and amortization of tangible and intangible assets and stock-based compensation. Symbotic defines adjusted selling, general, and administrative expenses, a non-GAAP financial measure, as GAAP selling, general, and administrative expenses excluding the following items: depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; internal control remediation; business transformation costs; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less purchases of property and equipment and capitalization of internal use software development costs. In addition to Symbotic’s financial results determined in accordance with U.S. GAAP, Symbotic believes that adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow non-GAAP financial measures, are useful in evaluating the performance of Symbotic’s business because they highlight trends in its core business.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, Symbotic’s expectations or predictions of future financial or business performance or conditions. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning our possible or assumed future actions, business strategies, events, backlog or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or similar expressions.

Forward-looking statements include, but are not limited to, statements about the ability of or expectations regarding, Symbotic to:

  • meet the technical requirements of existing or future supply agreements with its customers, including with respect to existing backlog;

  • expand its target customer base and maintain its existing customer base;

  • realize the benefits expected from the acquisition of Walmart’s Advanced Systems and Robotics business, the GreenBox joint venture, the Commercial Agreement with GreenBox, Symbotic’s acquisitions of developed technology intangible assets, and the commercial agreement with Walmart de México y Centroamérica;

  • realize its outlook, including its system gross margin;

  • anticipate industry trends;

  • maintain and enhance its system;

  • maintain the listing of the Symbotic Class A Common Stock on Nasdaq;

  • execute its growth strategy;

  • develop, design and sell systems that are differentiated from those of competitors;

  • execute its research and development strategy;

  • acquire, maintain, protect and enforce intellectual property;

  • attract, train and retain effective officers, key employees or directors;

  • comply with laws and regulations applicable to its business;

  • stay abreast of modified or new laws and regulations applying to its business;

  • successfully defend litigation;

  • issue equity securities in connection with future transactions;

  • meet future liquidity requirements and, if applicable, comply with restrictive covenants related to long-term indebtedness;

  • timely and effectively remediate any material weaknesses in its internal control over financial reporting;

  • anticipate rapid technological changes; and

  • effectively respond to general economic and business conditions.

Forward-looking statements also include, but are not limited to, statements with respect to:

  • the future performance of Symbotic’s business and operations;

  • expectations regarding revenues, expenses, adjusted EBITDA and anticipated cash needs;

  • expectations regarding cash flow, liquidity and sources of funding;

  • the next generation storage structure;

  • expectations regarding capital expenditures;

  • the anticipated benefits of Symbotic’s leadership structure;

  • the effects of pending and future legislation, regulation and trade practices, including tariffs;

  • business disruption;

  • disruption to the business due to Symbotic’s dependency on certain customers;

  • increasing competition in the warehouse automation industry;

  • any delays in the design, production or launch of Symbotic’s systems and products;

  • the failure to meet customers’ requirements under existing or future contracts or customer’s expectations as to price or pricing structure;

  • any defects in new products or enhancements to existing products;

  • the fluctuation of operating results from period to period due to a number of factors, including the pace of customer adoption of Symbotic’s new products and services and any changes in its product mix that shift too far into lower gross margin products; and

  • any consequences associated with joint ventures and legislative and regulatory actions and reforms.

Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed in Symbotic’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024, filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 4, 2024. These risk factors will be important to consider in determining future results and should be reviewed in their entirety. These forward-looking statements are expressed in good faith, and Symbotic believes there is a reasonable basis for them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management’s current expectations and plans relating to the future, and the reader is cautioned not to place undue reliance on these forward-looking statements because of their inherent uncertainty and to appreciate the limited purposes for which they are being used by management. While we believe that the assumptions and expectations reflected in the forward-looking statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-looking statements speak only as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. Symbotic is not under any obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that Symbotic has filed or will file from time to time with the SEC.

In addition to factors previously disclosed in Symbotic’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024 filed with the SEC on December 4, 2024 and those identified elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: failure to realize the benefits expected from the acquisition of Walmart’s Advanced Systems and Robotics business and risks related to the acquisition.

Any financial projections in this press release or discussed in the webcast are forward-looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond Symbotic’s control. While all projections are necessarily speculative, Symbotic believes that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection extends from the date of preparation. The assumptions and estimates underlying the projected results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. The inclusion of projections in this communication should not be regarded as an indication that Symbotic, or its representatives, considered or considers the projections to be a reliable prediction of future events.

Annualized, projected and estimated numbers are not forecasts and may not reflect actual results.

This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Symbotic and is not intended to form the basis of an investment decision in Symbotic. The forward-looking statements contained in this press release and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.

INVESTOR RELATIONS CONTACT

Charlie Anderson
Vice President, Investor Relations & Corporate Development
ir@symbotic.com

MEDIA INQUIRIES

mediainquiry@symbotic.com

Symbotic Inc. and Subsidiaries
Consolidated Statements of Operations

 

Three Months Ended

 

Nine Months Ended

 (in thousands, except share and per share information)

June 28, 2025

 

March 29, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Revenue:

 

 

 

 

 

 

 

 

 

Systems

$

559,108

 

 

$

513,372

 

 

$

450,595

 

 

$

1,536,539

 

 

$

1,168,993

 

Software maintenance and support

 

8,121

 

 

 

6,685

 

 

 

3,545

 

 

 

20,331

 

 

 

8,280

 

Operation services

 

24,892

 

 

 

29,594

 

 

 

16,198

 

 

 

71,595

 

 

 

46,340

 

Total revenue

 

592,121

 

 

 

549,651

 

 

 

470,338

 

 

 

1,628,465

 

 

 

1,223,613

 

Cost of revenue:

 

 

 

 

 

 

 

 

 

Systems

 

457,911

 

 

 

414,560

 

 

 

398,761

 

 

 

1,254,289

 

 

 

1,024,832

 

Software maintenance and support

 

1,756

 

 

 

2,095

 

 

 

2,539

 

 

 

5,735

 

 

 

6,201

 

Operation services

 

24,832

 

 

 

25,168

 

 

 

14,065

 

 

 

72,952

 

 

 

43,331

 

Total cost of revenue

 

484,499

 

 

 

441,823

 

 

 

415,365

 

 

 

1,332,976

 

 

 

1,074,364

 

Gross profit

 

107,622

 

 

 

107,828

 

 

 

54,973

 

 

 

295,489

 

 

 

149,249

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development expenses

 

52,147

 

 

 

61,540

 

 

 

44,722

 

 

 

157,279

 

 

 

133,327

 

Selling, general, and administrative expenses

 

75,670

 

 

 

78,347

 

 

 

47,871

 

 

 

215,092

 

 

 

143,535

 

Restructuring charges

 

16,361

 

 

 

 

 

 

 

 

 

16,361

 

 

 

 

Total operating expenses

 

144,178

 

 

 

139,887

 

 

 

92,593

 

 

 

388,732

 

 

 

276,862

 

Operating loss

 

(36,556

)

 

 

(32,059

)

 

 

(37,620

)

 

 

(93,243

)

 

 

(127,613

)

Other income, net

 

8,451

 

 

 

11,714

 

 

 

11,615

 

 

 

27,987

 

 

 

27,626

 

Loss before income tax and equity method investment

 

(28,105

)

 

 

(20,345

)

 

 

(26,005

)

 

 

(65,256

)

 

 

(99,987

)

Income tax expense (benefit)

 

(44

)

 

 

1,397

 

 

 

(182

)

 

 

1,204

 

 

 

(102

)

Loss from equity method investment

 

(3,776

)

 

 

(2,490

)

 

 

(537

)

 

 

(7,831

)

 

 

(537

)

Net loss

 

(31,925

)

 

 

(21,438

)

 

 

(26,724

)

 

 

(71,883

)

 

 

(100,626

)

Net loss attributable to noncontrolling interests

 

(26,012

)

 

 

(17,513

)

 

 

(22,043

)

 

 

(58,569

)

 

 

(84,300

)

Net loss attributable to common stockholders

$

(5,913

)

 

$

(3,925

)

 

$

(4,681

)

 

$

(13,314

)

 

$

(16,326

)

 

 

 

 

 

 

 

 

 

 

Loss per share of Class A Common Stock:

 

 

 

 

 

 

 

 

 

Basic and Diluted

$

(0.05

)

 

$

(0.04

)

 

$

(0.05

)

 

 

(0.12

)

 

$

(0.18

)

Weighted-average shares of Class A Common Stock outstanding:

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

109,201,745

 

 

 

107,726,978

 

 

 

102,414,284

 

 

 

107,664,864

 

 

 

92,891,276

 

 

Symbotic Inc. and Subsidiaries
Reconciliation of Non-GAAP Financial Measures

 

The following table reconciles GAAP net loss to Adjusted EBITDA:

 

Three Months Ended

 

Nine Months Ended

(in thousands)

June 28, 2025

 

March 29, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Net loss

$

(31,925

)

 

$

(21,438

)

 

$

(26,724

)

 

$

(71,883

)

 

$

(100,626

)

Interest income

 

(8,373

)

 

 

(7,229

)

 

 

(11,610

)

 

 

(23,371

)

 

 

(27,554

)

Income tax expense (benefit)

 

44

 

 

 

(1,397

)

 

 

182

 

 

 

(1,204

)

 

 

102

 

Depreciation and amortization

 

12,940

 

 

 

11,169

 

 

 

10,032

 

 

 

30,969

 

 

 

15,065

 

Stock-based compensation

 

50,279

 

 

 

47,962

 

 

 

30,320

 

 

 

126,982

 

 

 

94,508

 

Business Combination transaction expenses

 

422

 

 

 

3,298

 

 

 

 

 

 

7,522

 

 

 

 

Equity method investment

 

3,776

 

 

 

2,490

 

 

 

537

 

 

 

7,831

 

 

 

537

 

Internal control remediation

 

1,795

 

 

 

2,175

 

 

 

 

 

 

7,046

 

 

 

 

Business transformation costs

 

75

 

 

 

2,400

 

 

 

 

 

 

2,475

 

 

 

 

Fair value adjustments on strategic investments

 

 

 

 

(4,481

)

 

 

 

 

 

(4,481

)

 

 

 

Restructuring charges

 

16,361

 

 

 

(231

)

 

 

 

 

 

16,130

 

 

 

34,206

 

Joint venture formation fees

 

 

 

 

 

 

 

 

 

 

 

 

 

1,089

 

Equity financing transaction costs

 

 

 

 

 

 

 

 

 

 

 

 

 

1,985

 

Adjusted EBITDA

$

45,394

 

 

$

34,718

 

 

$

2,737

 

 

$

98,016

 

 

$

19,312

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles GAAP gross profit to Adjusted gross profit:

 

Three Months Ended

 

Nine Months Ended

(in thousands)

June 28, 2025

 

March 29, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Gross profit

$

107,622

 

 

$

107,828

 

 

$

54,973

 

 

$

295,489

 

 

$

149,249

 

Depreciation

 

3,538

 

 

 

2,949

 

 

 

5,359

 

 

 

8,957

 

 

 

5,540

 

Stock-based compensation

 

16,034

 

 

 

11,264

 

 

 

3,807

 

 

 

31,006

 

 

 

12,394

 

Restructuring charges

 

 

 

 

(231

)

 

 

 

 

 

(231

)

 

 

34,206

 

Adjusted gross profit

$

127,194

 

 

$

121,810

 

 

$

64,139

 

 

$

335,221

 

 

$

201,389

 


Gross profit margin

 

18.2

%

 

 

19.6

%

 

 

11.7

%

 

 

18.1

%

 

 

12.2

%

Adjusted gross profit margin

 

21.5

%

 

 

22.2

%

 

 

13.6

%

 

 

20.6

%

 

 

16.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles GAAP research and development expenses to Adjusted research and development expenses:

 

Three Months Ended

 

Nine Months Ended

(in thousands)

June 28, 2025

 

March 29, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Research and development expenses

$

52,147

 

 

$

61,540

 

 

$

44,722

 

 

$

157,279

 

 

$

133,327

 

Depreciation and amortization

 

(7,133

)

 

 

(5,611

)

 

 

(1,250

)

 

 

(15,044

)

 

 

(3,236

)

Stock-based compensation

 

(12,860

)

 

 

(15,608

)

 

 

(13,279

)

 

 

(40,719

)

 

 

(41,728

)

Adjusted research and development expenses

$

32,154

 

 

$

40,321

 

 

$

30,193

 

 

$

101,516

 

 

$

88,363

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles GAAP selling, general, and administrative expenses to Adjusted selling, general, and administrative expenses:

 

Three Months Ended

 

Nine Months Ended

(in thousands)

June 28, 2025

 

March 29, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Selling, general, and administrative expenses

$

75,670

 

 

$

78,347

 

 

$

47,871

 

 

$

215,092

 

 

$

143,535

 

Depreciation and amortization

 

(2,270

)

 

 

(2,609

)

 

 

(3,423

)

 

 

(6,969

)

 

 

(6,294

)

Stock-based compensation

 

(21,385

)

 

 

(21,091

)

 

 

(13,235

)

 

 

(55,257

)

 

 

(40,385

)

Business combination transaction expenses

 

(422

)

 

 

(3,298

)

 

 

 

 

 

(7,522

)

 

 

 

Internal control remediation

 

(1,795

)

 

 

(2,175

)

 

 

 

 

 

(7,046

)

 

 

 

Business transformation costs

 

(75

)

 

 

(2,400

)

 

 

 

 

 

(2,475

)

 

 

 

Joint venture formation fees

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,089

)

Equity financing transaction costs

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,985

)

Adjusted selling, general, and administrative expenses

$

49,723

 

 

$

46,774

 

 

$

31,213

 

 

$

135,823

 

 

$

93,782

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles GAAP net cash provided by (used in) operating activities to free cash flow:

 

Three Months Ended

 

Nine Months Ended

(in thousands)

June 28, 2025

 

March 29, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Net cash provided by (used in) operating activities

$

(138,343

)

 

$

269,575

 

 

$

50,384

 

 

$

336,259

 

 

$

41,306

 

Purchases of property and equipment and capitalization of internal use software development costs

 

(14,867

)

 

 

(20,560

)

 

 

(17,143

)

 

 

(42,784

)

 

 

(23,007

)

Free cash flow

$

(153,210

)

 

$

249,015

 

 

$

33,241

 

 

$

293,475

 

 

$

18,299

 

 

Symbotic Inc. and Subsidiaries
Supplemental Common Share Information

 

Total Common Shares issued and outstanding:

 

June 28, 2025

 

September 28, 2024

Class A Common Shares issued and outstanding

 

110,252,933

 

 

 

104,689,377

 

Class V-1 Common Shares issued and outstanding

 

76,015,171

 

 

 

76,965,386

 

Class V-3 Common Shares issued and outstanding

 

403,559,196

 

 

 

404,309,196

 

 

 

589,827,300

 

 

 

585,963,959

 

 

 

 

 

 

 

 

 


Symbotic Inc. and Subsidiaries
Consolidated Balance Sheets

 

(in thousands, except share data)

June 28, 2025

 

September 28, 2024

ASSETS

Current assets:

 

 

 

Cash and cash equivalents

$

777,576

 

 

$

727,310

 

Accounts receivable

 

136,237

 

 

 

201,548

 

Unbilled accounts receivable

 

236,433

 

 

 

218,233

 

Inventories

 

138,901

 

 

 

106,136

 

Deferred expenses

 

35,545

 

 

 

1,058

 

Prepaid expenses and other current assets

 

101,516

 

 

 

101,252

 

Total current assets

 

1,426,208

 

 

 

1,355,537

 

Property and equipment, net

 

73,013

 

 

 

97,109

 

Intangible assets, net

 

82,921

 

 

 

3,664

 

Goodwill

 

60,534

 

 

 

 

Equity method investment

 

105,551

 

 

 

81,289

 

Other assets

 

79,184

 

 

 

40,953

 

Total assets

$

1,827,411

 

 

$

1,578,552

 

LIABILITIES AND EQUITY

Current liabilities:

 

 

 

Accounts payable

$

215,624

 

 

$

175,188

 

Accrued expenses and other current liabilities

 

183,690

 

 

 

165,644

 

Deferred revenue

 

918,097

 

 

 

676,314

 

Total current liabilities

 

1,317,411

 

 

 

1,017,146

 

Deferred revenue

 

5,044

 

 

 

129,233

 

Other liabilities

 

61,544

 

 

 

42,043

 

Total liabilities

 

1,383,999

 

 

 

1,188,422

 

Commitments and contingencies

 

 

 

 

 

Equity:

 

 

 

Class A Common Stock, 3,000,000,000 shares authorized, 110,252,933 and 104,689,377 shares issued and outstanding at June 28, 2025 and September 28, 2024, respectively

 

13

 

 

 

13

 

Class V-1 Common Stock, 1,000,000,000 shares authorized, 76,015,171 and 76,965,386 shares issued and outstanding at June 28, 2025 and September 28, 2024, respectively

 

7

 

 

 

7

 

Class V-3 Common Stock, 450,000,000 shares authorized, 403,559,196 and 404,309,196 shares issued and outstanding at June 28, 2025 and September 28, 2024, respectively

 

40

 

 

 

40

 

Additional paid-in capital

 

1,550,610

 

 

 

1,523,692

 

Accumulated deficit

 

(1,337,239

)

 

 

(1,323,925

)

Accumulated other comprehensive loss

 

(2,678

)

 

 

(2,594

)

Total stockholders' equity

 

210,753

 

 

 

197,233

 

Noncontrolling interest

 

232,659

 

 

 

192,897

 

Total equity

 

443,412

 

 

 

390,130

 

Total liabilities and equity

$

1,827,411

 

 

$

1,578,552

 

 

 

 

 

 

 

 

 


Symbotic Inc. and Subsidiaries
Consolidated Statements of Cash Flows

 

 

Three Months Ended

 

Nine Months Ended

(in thousands)

June 28, 2025

 

March 29, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net loss

$

(31,925

)

 

$

(21,438

)

 

$

(26,724

)

 

$

(71,883

)

 

$

(100,626

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

14,202

 

 

 

12,279

 

 

 

10,696

 

 

 

34,126

 

 

 

17,048

 

Loss from equity method investment

 

3,776

 

 

 

4,055

 

 

 

537

 

 

 

7,831

 

 

 

537

 

Foreign currency (gains) losses, net

 

(61

)

 

 

20

 

 

 

 

 

 

(73

)

 

 

(8

)

Gain on investments

 

 

 

 

 

 

 

(1,339

)

 

 

 

 

 

(10,084

)

Loss on disposal of assets

 

 

 

 

 

 

 

 

 

 

201

 

 

 

 

Provision for excess and obsolete inventory

 

3,921

 

 

 

292

 

 

 

(171

)

 

 

4,901

 

 

 

34,105

 

Stock-based compensation

 

49,440

 

 

 

43,355

 

 

 

29,331

 

 

 

119,568

 

 

 

86,858

 

Gain from strategic investment fair value adjustment

 

 

 

 

(4,481

)

 

 

 

 

 

(4,481

)

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

1,389

 

 

 

(3,195

)

 

 

27,166

 

 

 

65,570

 

 

 

(31,295

)

Inventories

 

3,470

 

 

 

(23,232

)

 

 

(12,179

)

 

 

(30,187

)

 

 

(30,099

)

Prepaid expenses and other current assets

 

(37,107

)

 

 

89,491

 

 

 

45,269

 

 

 

62,701

 

 

 

2,839

 

Deferred expenses

 

27,503

 

 

 

(1,757

)

 

 

(5,580

)

 

 

23,582

 

 

 

(10,626

)

Other assets

 

(9,449

)

 

 

(6,400

)

 

 

514

 

 

 

(16,928

)

 

 

(4,952

)

Accounts payable

 

(4,407

)

 

 

13,806

 

 

 

(5,444

)

 

 

40,544

 

 

 

17,871

 

Accrued expenses and other current liabilities

 

12,532

 

 

 

(65,685

)

 

 

50,477

 

 

 

(7,613

)

 

 

48,593

 

Deferred revenue

 

(171,331

)

 

 

230,283

 

 

 

(60,635

)

 

 

117,288

 

 

 

12,009

 

Other liabilities

 

(296

)

 

 

2,182

 

 

 

(1,534

)

 

 

(8,888

)

 

 

9,136

 

Net cash provided by (used in) operating activities

 

(138,343

)

 

 

269,575

 

 

 

50,384

 

 

 

336,259

 

 

 

41,306

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Purchases of property and equipment and capitalization of internal use software development costs

 

(14,867

)

 

 

(20,560

)

 

 

(17,143

)

 

 

(42,784

)

 

 

(23,007

)

Proceeds from maturities of marketable securities

 

 

 

 

 

 

 

50,000

 

 

 

 

 

 

340,000

 

Purchases of marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

(48,660

)

Acquisitions of strategic investments

 

(24,233

)

 

 

 

 

 

(66,489

)

 

 

(42,225

)

 

 

(66,489

)

Cash paid for business acquisitions

 

 

 

 

(200,000

)

 

 

 

 

 

(200,000

)

 

 

 

Net cash provided by (used in) investing activities

 

(39,100

)

 

 

(220,560

)

 

 

(33,632

)

 

 

(285,009

)

 

 

201,844

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Payment for taxes related to net share settlement of stock-based compensation awards

 

 

 

 

 

 

 

 

 

 

(3,012

)

 

 

(3,181

)

Net proceeds from issuance of common stock under employee stock purchase plan

 

 

 

 

3,233

 

 

 

 

 

 

3,233

 

 

 

3,435

 

Distributions to or on behalf of Symbotic Holdings LLC partners

 

57

 

 

 

(382

)

 

 

(47,654

)

 

 

(1,175

)

 

 

(47,654

)

Proceeds from issuance of Class A Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

257,985

 

Proceeds from exercise of warrants

 

 

 

 

 

 

 

2

 

 

 

 

 

 

158,704

 

Net cash provided by (used in) financing activities

 

57

 

 

 

2,851

 

 

 

(47,652

)

 

 

(954

)

 

 

369,289

 

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

24

 

 

 

50

 

 

 

(10

)

 

 

(10

)

 

 

(25

)

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

(177,362

)

 

 

51,916

 

 

 

(30,910

)

 

 

50,286

 

 

 

612,414

 

Cash, cash equivalents, and restricted cash - beginning of period

 

958,002

 

 

 

906,086

 

 

 

904,242

 

 

 

730,354

 

 

 

260,918

 

Cash, cash equivalents, and restricted cash - end of period

$

780,640

 

 

$

958,002

 

 

$

873,332

 

 

$

780,640

 

 

$

873,332

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

(in thousands)

June 28, 2025

 

March 29, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Reconciliation of cash, cash equivalents, and restricted cash:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

777,576

 

 

$

954,944

 

 

$

870,469

 

 

$

777,576

 

 

$

870,469

 

Restricted cash

 

3,064

 

 

 

3,058

 

 

 

2,863

 

 

 

3,064

 

 

 

2,863

 

Cash, cash equivalents, and restricted cash

$

780,640

 

 

$

958,002

 

 

$

873,332

 

 

$

780,640

 

 

$

873,332